Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.